| 摘要 |
The invention is a treatment for coronary conditions by delivering a therapeutic agent to the pericardial space. The therapeutic agent can be delivered by internal entry through the atrium or ventricle, or by external entry through the chest cavity. The therapeutic agent can be a polypeptide, polynucleotide or other drug.
|
